Clinical Research in Southampton
Southampton Children's Hospital

A A A Text only | Accessibility | Privacy and cookies

Home
About the Trust
Our services
Patients and visitors
Our hospitals
Education
Research
Working here
Contact us

Browse site A to Z

A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z

Search results

Go To Advanced Search

Search

You could also try: resume (344), start again (306), save (202)

Public and patients

Description: Auto Generated Title Southampton is part of the national effort to prevent, diagnose and treat COVID-19 – see a list of
Url: /ClinicalResearchinSouthampton/Public-and-patients/Public-and-patients.aspx

Carboplatin(AUC6)-Paclitaxel-Pembrolizumab

Description: Chemotherapy Protocol LUNG CANCER CARBOPLATIN (AUC6)-PACLITAXEL-PEMBROLIZUMAB Regimen • Lung-Carboplatin (AUC6)-Paclitaxel-Pembrolizumab Indication - The patient has a histologically- or
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Lung-cancer-non-small-cellNSCLC/CarboplatinAUC6-Paclitaxel-Pembrolizumab.pdf

Azacitidine(SC)-Venetoclax

Description: Chemotherapy Protocol Acute Myeloid Leukaemia AZACITIDINE (SC) - VENETOCLAX Regimen  AML – Azacitidine (SC) - Venetoclax Indication  Newly diagnosed a
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/AML/AzacitidineSC-Venetoclax.pdf

Extensor tendon repair (zones 4 to 7) - Norwich regime or controlled active motion regime) - patient information

Description: This factsheet explains what the Norwich regime (also known as the controlled active motion regime) rehabilitation programme is and what it
Url: /Media/UHS-website-2019/Patientinformation/Medicinestherapiesandanaesthetics/Extensor-tendon-repair-zones-4-to-7-Norwich-regime-or-controlled-active-motion-regime-3962-PIL.pdf

DRD Daratumumab-Lenalidomide-Dexamethasone

Description: Chemotherapy Protocol Myeloma DRD Daratumumab-Lenalidomide-Dexamethasone Regimen • Myeloma – DRD Daratumumab-Lenalidomide-Dexamethasone
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Myeloma/DRD-Daratumumab-Lenalidomide-Dexamethasone.pdf

Osimertinib

Description: Chemotherapy Protocol Lung cancer - Non-small cell (NSCLC) OSIMERTINIB Regimen • NSCLC - Osimertinib Indic
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Lung-cancer-non-small-cellNSCLC/Osimertinib.pdf

Capecitabine-Radiotherapy

Description: Chemotherapy Protocol PANCREATIC CANCER CAPECITABINE (RADIOTHERAPY) Regimen • Pancreatic Cancer – Cap
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Pancreas/Capecitabine-Radiotherapy.pdf

UHS AR 22-23-6

Description: 2022/23 Incorporating the quality account University Hospital Southampton NHS Foundation Trust Annual Report and Accounts 2022/23 Presented to Parliament
Url: /Media/UHS-website-2019/Docs/About-the-Trust/Annual-reports-and-quality-accounts/UHS-AR-22-23-6.pdf

Bevacizumab (15) Carboplatin-Paclitaxel (21 day)

Description: Chemotherapy Protocol GYNAECOLOGICAL CANCER BEVACIZUMAB (15)-CARBOPLATIN (AUC5)-PACLITAXEL (21 day) Regimen • Cervix-Bevacizumab (15)-Carboplatin (AUC5)-Paclitaxel (21 day) Indication
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Cervical-cancer/Bevacizumab-15-Carboplatin-Paclitaxel-21-day.pdf

Neratinib

Description: Chemotherapy Protocol Breast Cancer NERATINIB Regimen • Breast Cancer – Neratinib Indication • Neratinib for extended adjuvant therapy for hormone receptor positive HER2overexpressed early
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Breastcancer/Neratinib.pdf

71 to 80 of 219

Previous … 6 7 8 9 10 … Next